Items per page
1 - 198 of 198
Title Published in Access level OA Policy Year Views Downloads
Routine Immunisation Coverage Shows Signs of Recovery at Global Level Postpandemic, but Important Declines Persist in About 20% of CountriesVaccines
accessLevelPublic
2025 43 52
Long-term levels of protection of different types of immunity against the Omicron variant : a rapid literature reviewSwiss medical weekly
accessLevelPublic
2024 81 64
Swiss COVID-19 hospital surveillance : an in-depth analysis of the factors associated with hospital readmission dynamics in community-acquired COVID-19 casesSwiss medical weekly
accessLevelPublic
2024 74 97
Association of institutional masking policies with healthcare-associated SARS-CoV-2 infections in Swiss acute care hospitals during the BA.4/5 wave (CH-SUR study) : a retrospective observational studyAntimicrobial resistance and infection control
accessLevelPublic
2024 68 52
Clinical severity of Delta and 3 different Omicron sublineages in patients hospitalized because of COVID-19 in a Swiss tertiary centerCMI communications
accessLevelPublic
2024 56 49
Infectious disease events in people with HIV receiving kidney transplantation : Analysis of the Swiss HIV Cohort Study and the Swiss Transplant Cohort StudyBMC infectious diseases
accessLevelPublic
2024 50 64
Factors Associated with Reliable Contact Tracing During the 2021 Ebola Virus Disease Outbreak in GuineaJournal of epidemiology and global health
accessLevelPublic
2024 174 55
Evaluating tuberculosis treatment outcomes in Haiti from 2018 to 2019 : A competing risk analysisIJID regions
accessLevelPublic
2024 73 66
Immune response to the recombinant herpes zoster vaccine in people living with HIV over 50 years of age compared to non-HIV age-/gender-matched controls (SHINGR’HIV) : a multicenter, international, non-randomized clinical trial study protocolBMC infectious diseases
accessLevelPublic
2024 103 70
In-hospital outcomes of healthcare-associated COVID-19 (Omicron) versus healthcare-associated influenza : a retrospective, nationwide cohort study in SwitzerlandClinical infectious diseases
accessLevelPublic
2024 46 78
Population Pharmacokinetics of Cabotegravir Following Oral Administration and Long‐Acting Intramuscular Injection in Real‐World People with HIVClinical pharmacology and therapeutics
accessLevelPublic
2024 76 25
Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3)The journal of infectious diseases
accessLevelPublic
2024 493 399
Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral TherapyClinical infectious diseases
accessLevelPublic
2023 95 65
Analysis of global routine immunisation coverage shows disruption and stagnation during the first two-years of the COVID-19 pandemic with tentative recovery in 2022Vaccine. X
accessLevelPublic
2023 56 15
Antiretroviral Drug Exposure and Response in Obese and Morbidly Obese People With Human Immunodeficiency Virus (HIV) : A Study Combining Modelling and Swiss HIV Cohort DataClinical infectious diseases
accessLevelPublic
2023 103 54
Investing in preparedness for rapid detection and control of epidemics: analysis of health system reforms and their effect on 2021 Ebola virus disease epidemic response in GuineaBMJ global health
accessLevelPublic
2023 366 95
Viral suppression and retention in HIV care during the postpartum period among women living with HIV : a longitudinal multicenter cohort studyThe Lancet regional health. Europe
accessLevelPublic
2023 56 11
Historical visit attendance as predictor of treatment interruption in South African HIV patients : Extension of a validated machine learning modelPLOS global public health
accessLevelPublic
2023 58 118
Effect of SLCO1B1 c.521T>C polymorphism on the lipid response to statins in people living with HIV on a boosted protease inhibitor‐containing regimenBritish journal of clinical pharmacology
accessLevelPublic
2023 97 44
External validation of the Dat'AIDS score : A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or olderHIV medicine
accessLevelPublic
2023 84 49
The spatial spread of HIV in Malawi : An individual-based mathematical modelHeliyon
accessLevelPublic
2023 75 51
An Automated Literature Review Tool (LiteRev) for Streamlining and Accelerating Research Using Natural Language Processing and Machine Learning: Descriptive Performance Evaluation StudyJMIR. Journal of medical internet research
accessLevelPublic
2023 153 114
Hepatitis B Virus (HBV) Replication During Tenofovir Therapy Is Frequent in Human Immunodeficiency Virus/HBV CoinfectionClinical infectious diseases
accessLevelRestricted
2023 105 0
COVID-19 preventive social-behavioural practices and exposure to SARS-CoV-2 among residents in the city of Yaounde : Lessons from the early phase of the pandemic in CameroonPLOS global public health
accessLevelPublic
2023 59 55
Differences between persons with and without disability in HIV prevalence, testing, treatment, and care cascade in Tanzania : a cross-sectional study using population-based dataBMC public health
accessLevelPublic
2023 92 82
Comparison of five different risk scores to predict incident type 2 diabetes in the Swiss HIV cohort studyAIDS
accessLevelPublic
2023 110 35
Association of a Polygenic Risk Score With Osteoporosis in People Living With HIV : The Swiss HIV Cohort StudyThe Journal of infectious diseases
accessLevelPublic
2023 87 19
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2)Open forum infectious diseases
accessLevelPublic
2023 78 48
Triggers of change in sexual behavior among people with HIV: The Swiss U = U statement and Covid-19 comparedThe journal of infectious diseases
accessLevelPublic
2023 110 59
A community-based contact isolation strategy to reduce the spread of Ebola virus disease: an analysis of the 2018-2020 outbreak in the Democratic Republic of the CongoBMJ global health
accessLevelPublic
2023 173 67
Polygenic Risk Scores for Prediction of Subclinical Coronary Artery Disease in Persons With Human Immunodeficiency Virus (HIV): The Swiss HIV Cohort StudyClinical infectious diseases
accessLevelPublic
2023 96 34
Antibody Response After Third Vaccination With mRNA-1273 or BNT162b2 : Extension of a Randomized Controlled SARS-CoV-2 Noninferiority Vaccine Trial in Patients With Different Levels of Immunosuppression (COVERALL-2)Open forum infectious diseases
accessLevelPublic
2023 128 61
Sexual Behaviour and STI Incidence in Sexually Active MSM Living With HIV in Times of COVID-19Open forum infectious diseases
accessLevelPublic
2023 103 60
Prevalence of HIV-1 drug resistance mutations in proviral DNA in the Swiss HIV Cohort Study, a retrospective study from 1995 to 2018The journal of antimicrobial chemotherapy
accessLevelPublic
2023 129 122
Treatment effect of remdesivir on the mortality of hospitalised COVID-19 patients in Switzerland across different patient groups : a tree-based model analysisSwiss medical weekly
accessLevelPublic
2023 69 30
A Platform for Data-Centric, Continuous Epidemiological Analyses (EpiGraphHub) : Descriptive AnalysisJMIR. Journal of medical internet research
accessLevelPublic
2023 77 61
Dolutegravir in Pregnancy as Compared with Current HIV Regimens in the United StatesNew England journal of medicine
accessLevelRestricted
2022 104 0
Factors associated with the risk of HIV infection among HIV-exposed infants in Malawi : 2013-2020BMJ paediatrics open
accessLevelPublic
2022 75 32
Sub optimal HIV status ascertainment at antenatal clinics and the impact on HIV prevalence estimates : A cross sectional studyPloS one
accessLevelPublic
2022 170 44
COVID-19 in Switzerland real-time epidemiological analyses powered by EpiGraphHubScientific data
accessLevelPublic
2022 70 19
Associations of Sustainable Development Goals Accelerators With Adolescents' Well-Being According to Head-of-Household's Disability Status-A Cross-Sectional Study From ZambiaInternational journal of public health
accessLevelPublic
2022 175 104
Case Report: COVID-19 and Lassa Fever Coinfection in an Ebola Suspected Patient in GuineaThe American journal of tropical medicine and hygiene
accessLevelPublic
2022 332 163
CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort StudyJournal of acquired immune deficiency syndromes
accessLevelPublic
2022 92 32
Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19Euro surveillance
accessLevelPublic
2022 282 115
Time to death and risk factors associated with mortality among COVID-19 cases in countries within the WHO African region in the early stages of the COVID-19 pandemicEpidemiology and infection
accessLevelPublic
2022 220 137
Transfer of antiretroviral drugs into breastmilk : a prospective study from the Swiss Mother and Child HIV Cohort StudyJournal of antimicrobial chemotherapy
accessLevelPublic
2022 89 42
A Systematic Molecular Epidemiology Screen Reveals Numerous Human Immunodeficiency Virus (HIV) Type 1 Superinfections in the Swiss HIV Cohort StudyThe journal of infectious diseases
accessLevelRestricted
2022 117 0
An in-depth statistical analysis of the COVID-19 pandemic's initial spread in the WHO African regionBMJ global health
accessLevelPublic
2022 273 103
Factors associated with HIV viral suppression among children and adults receiving antiretroviral therapy in Malawi in 2021: Evidence from the Laboratory Management Information SystemTM & IH. Tropical medicine and international health
accessLevelPublic
2022 114 28
Diagnosis and case finding according to key partner risk populations of people living with HIV in Nigeria: A retrospective analysis of community-led index partner testing servicesEClinicalMedicine
accessLevelPublic
2022 566 132
COVID-19 pandemic in Africa's island nations during the first 9 months: a descriptive study of variation in patterns of infection, severe disease, and response measuresBMJ global health
accessLevelPublic
2022 171 120
Investigation of and Strategies to Control the Final Cluster of the 2018–2020 Ebola Virus Disease Outbreak in the Eastern Democratic Republic of CongoOpen forum infectious diseases
accessLevelPublic
2022 283 104
Prediction of HIV status based on socio-behavioural characteristics in East and Southern AfricaPloS one
accessLevelPublic
2022 241 113
Leveraging human resources for outbreak analysis: lessons from an international collaboration to support the sub-Saharan African COVID-19 responseBMC public health
accessLevelPublic
2022 403 62
Geospatial model of COVID-19 spreading and vaccination with event Gillespie algorithmNonlinear dynamics
accessLevelPublic
2022 188 92
A call for citizen science in pandemic preparedness and response: beyond data collectionBMJ global health
accessLevelPublic
2022 232 66
Quantifying and predicting ongoing Human Immunodeficiency Virus Type 1 (HIV-1) transmission dynamics in Switzerland using a distance-based clustering approachThe journal of infectious diseases
accessLevelRestricted
2022 132 2
A highly virulent variant of HIV-1 circulating in the NetherlandsScience
accessLevelPublic
2022 181 44
Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patientsBMC infectious diseases
accessLevelPublic
2022 134 62
Decrease of condom use in heterosexual couples and its impact on pregnancy rates: the Swiss HIV Cohort Study (SHCS)HIV medicine
accessLevelPublic
2022 109 42
Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled TrialClinical infectious diseases
accessLevelPublic
2022 139 49
SARS-CoV-2 aerosol transmission in schools: the effectiveness of different interventionsSwiss medical weekly
accessLevelPublic
2022 248 132
Access to Social Protection by People Living with, at Risk of, or Affected by HIV in Eswatini, Malawi, Tanzania, and Zambia: Results from Population-Based HIV Impact AssessmentsAIDS and behavior
accessLevelPublic
2022 310 88
COVID-19 vaccines and post-vaccination data: Literature update (11) - 30.11.2021
accessLevelPublic
2021 418 169
Evolution of COVID-19 mortality over time: results from the Swiss hospital surveillance system (CH-SUR)Swiss medical weekly
accessLevelPublic
2021 404 106
Analysing the reported incidence of COVID-19 and factors associated in the World Health Organization African region as of 31 December 2020Epidemiology and infection
accessLevelPublic
2021 277 87
COVID-19 in the WHO African Region: using risk assessment to inform decisions on public health and social measuresEpidemiology and infection
accessLevelPublic
2021 306 111
Information management practices in the WHO African Region to support response to the COVID-19 pandemicEpidemiology and Infection
accessLevelPublic
2021 249 80
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (10) - 15.12.2021
accessLevelPublic
2021 385 148
Insights into household transmission of SARS-CoV-2 from a population-based serological surveyNature Communications
accessLevelPublic
2021 426 164
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (Updated Version 7) - 02.11.2021
accessLevelPublic
2021 254 71
COVID-19 vaccines and post-vaccination data: Literature update (9) - 30.09.2021
accessLevelPublic
2021 333 87
The COVID-19 pandemic in the WHO African region: the first year (February 2020 to February 2021)Epidemiology and infection
accessLevelPublic
2021 394 117
Estimating the SARS-CoV2 infections detection rate and cumulative incidence in the World Health Organization African Region ten months into the pandemicEpidemiology and infection
accessLevelPublic
2021 262 94
COVID-19 mortality in women and men in sub-Saharan Africa: a cross-sectional studyBMJ global health
accessLevelPublic
2021 292 122
COVID-19 vaccines and post-vaccination data: Literature update (12) - 20.12.2021
accessLevelPublic
2021 275 79
Risk factors for severe outcomes for COVID-19 patients hospitalised in Switzerland during the first pandemic wave, February to August 2020: prospective observational cohort studySwiss medical weekly
accessLevelPublic
2021 333 119
Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort StudyOpen Forum Infectious Diseases
accessLevelPublic
2021 305 151
Clusters of sub-Saharan African countries based on sociobehavioural characteristics and associated HIV incidencePeerJ
accessLevelPublic
2021 503 142
Novel Use of Capture-Recapture Methods to Estimate Completeness of Contact Tracing during an Ebola Outbreak, Democratic Republic of the Congo, 2018-2020Emerging infectious diseases
accessLevelPublic
2021 291 110
The first eight months of COVID-19 pandemic in three West African countries: leveraging lessons learned from responses to the 2014-2016 Ebola virus disease outbreakEpidemiology and infection
accessLevelPublic
2021 308 104
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (8) - 15.11.2021
accessLevelPublic
2021 289 123
Recommandations pour le suivi des patients atteints d'hépatite C guérieSwiss Medical Forum
accessLevelPublic
2021 226 151
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (4) - 13.09.2021
accessLevelPublic
2021 302 106
Evidence-based Definition for Extensively Drug-resistant TuberculosisAmerican Journal of Respiratory and Critical Care Medicine
accessLevelPublic
2021 342 336
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (6) - 15.10.2021
accessLevelPublic
2021 251 147
Implementing epidemic intelligence in the WHO African region for early detection and response to acute public health eventsEpidemiology and Infection
accessLevelPublic
2021 308 135
Assessing relative COVID-19 mortality: a Swiss population-based studyBMJ Open
accessLevelPublic
2021 413 100
Women with disabilities in hearing: the last mile in the elimination of mother-to-child transmission of HIV - a cross-sectional study from ZambiaAIDS care
accessLevelPublic
2021 252 107
Monitoring and Evaluation of COVID-19 response in the WHO African Region: challenges and lessons learnedEpidemiology and Infection
accessLevelPublic
2021 330 138
The role of children and adolescents in the SARS-CoV-2 pandemic: a rapid reviewSwiss medical weekly
accessLevelPublic
2021 323 123
COVID-19 vaccines and post-vaccination data: Literature update (Updated Version 10) - 02.11.2021
accessLevelPublic
2021 282 80
Cohort profile: SARS-CoV-2/COVID-19 hospitalised patients in SwitzerlandSwiss Medical Weekly
accessLevelPublic
2021 359 186
Tuberculosis in the Western Pacific Region: Estimating the burden of disease and return on investment 2020–2030 in four countriesThe Lancet Regional Health - Western Pacific
accessLevelPublic
2021 218 85
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (2) - 16.08.2021
accessLevelPublic
2021 289 158
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (3) - 30.08.2021
accessLevelPublic
2021 285 108
Evaluation of Early Warning, Alert and Response system for Ebola virus disease, Democratic Republic of the Congo, 2018–2020Emerging infectious diseases
accessLevelPublic
2021 391 146
COVID-19 vaccines and post-vaccination data: literature update (8) - 30.08.2021
accessLevelPublic
2021 407 76
Hepatitis C core antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysisPeerJ
accessLevelPublic
2021 352 93
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district in CameroonNature communications
accessLevelPublic
2021 288 126
Assessing relative COVID-19 mortality during the second wave: a prospective Swiss population-based studyBMJ open
accessLevelPublic
2021 210 75
A public health strategy for SARS-CoV-2, grounded in science, should guide Swiss schools through the coming winterSwiss medical weekly
accessLevelPublic
2021 402 131
Geographical Disparities in HIV Seroprevalence Among Men Who Have Sex with Men and People Who Inject Drugs in Nigeria: Exploratory Spatial Data AnalysisJMIR Public Health and Surveillance
accessLevelPublic
2021 350 278
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (9) - 30.11.2021
accessLevelPublic
2021 269 167
COVID-19 vaccines in the WHO's Emergency Use Listing (EUL) Report (5) - 30.09.2021
accessLevelPublic
2021 293 129
Systematic review of Integrated Disease Surveillance and Response (IDSR) implementation in the African regionPLOS ONE
accessLevelPublic
2021 404 256
Cohort-Derived Machine Learning Models for Individual Prediction of Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: A Prospective Multicenter Cohort StudyThe journal of infectious diseases
accessLevelPublic
2021 95 23
Facing the quality of life: physical illness, anxiety, and depression symptoms among people living with HIV in rural Zambia - a cross-sectional studyAIDS care
accessLevelPublic
2021 213 254
The toll of COVID-19 on African children: A descriptive analysis on the COVID-19-related morbidity and mortality among the pediatric population in Sub-Saharan AfricaInternational Journal of Infectious Diseases
accessLevelPublic
2021 212 150
The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort StudyJournal of clinical medicine
accessLevelPublic
2021 76 54
Precision global health: a roadmap for augmented actionJournal of Public Health and Emergency
accessLevelPublic
2020 981 366
Identifying groups of people with similar sociobehavioural characteristics in Malawi to inform HIV interventions: a latent class analysisJournal of the International AIDS society
accessLevelPublic
2020 319 123
Zimbabwe's national third-line antiretroviral therapy program: Cohort description and treatment outcomesPLOS ONE
accessLevelPublic
2020 253 129
Antiretroviral Drugs Associated With Subclinical Coronary Artery Disease in the Swiss Human Immunodeficiency Virus Cohort StudyClinical Infectious Diseases
accessLevelRestricted
2020 228 0
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studyThe Lancet
accessLevelRestricted
2020 765 14
Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIVPLoS biology
accessLevelPublic
2020 89 18
Future scenarios for the SARS-CoV-2 epidemic in Switzerland: an age-structured modelF1000Research
accessLevelPublic
2020 374 64
Mortality trends and causes of death among HIV positive patients at Newlands Clinic in Harare, ZimbabwePLOS ONE
accessLevelPublic
2020 313 128
Use of electronic tools for evidence-based preparedness and response to the COVID-19 pandemic in the WHO African regionThe Lancet Digital Health
accessLevelPublic
2020 282 129
Social determinants of male partner attendance in women's prevention-of mother-to-child transmission program in MalawiBMC Public Health
accessLevelPublic
2020 267 153
Social, Behavioral, and Cultural factors of HIV in Malawi: Semi-Automated Systematic ReviewJournal of Medical Internet Research
accessLevelPublic
2020 355 612
Measuring Timeliness of Outbreak Response in the World Health Organization African Region, 2017-2019Emerging Infectious Diseases
accessLevelPublic
2020 308 89
How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?HIV medicine
accessLevelPublic
2020 109 27
Impact of Genetic and Nongenetic Factors on Body Mass Index and Waist-Hip Ratio Change in HIV-Infected Individuals Initiating Antiretroviral TherapyOpen Forum Infectious Diseases
accessLevelPublic
2020 222 112
All-Cause mortality and causes of death in the Swiss Hepatitis C Cohort Study (SCCS)Open Forum Infectious Diseases
accessLevelPublic
2020 375 161
Variations in tuberculosis prevalence, russian federation: a multivariate approachBulletin of the World Health Organization
accessLevelPublic
2019 461 275
Precision Global Health - The case of Ebola: a scoping reviewJournal of Global Health
accessLevelPublic
2019 655 294
Modelling the impact of different testing strategies for HCV infection in switzerlandJournal of virus eradication
accessLevelPublic
2019 409 95
Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in Southern Africa: health economic and modelling analysisJournal of the International AIDS society
accessLevelPublic
2019 439 213
Long-term retention on antiretroviral therapy among infants, children, adolescents and adults in Malawi: A cohort studyPLOS ONE
accessLevelPublic
2019 330 134
Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort StudyPLOS ONE
accessLevelPublic
2019 459 201
Emtricitabine and lamivudine concentrations in saliva: a simple suitable test for treatment adherenceThe journal of antimicrobial chemotherapy
accessLevelRestricted
2019 78 0
"I do all I can but I still fail them": Health system barriers to providing Option B+ to pregnant and lactating women in MalawiPLOS ONE
accessLevelPublic
2019 380 179
Changing trends in international versus domestic HCV transmission in HIV-positive MSM: A perspective for the DAA scale-up eraThe Journal of Infectious Diseases
accessLevelPublic
2019 797 230
A case report of untreatable HIV infection in Harare, ZimbabweSouthern African Journal of HIV Medicine
accessLevelPublic
2019 374 135
Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017Journal of the International AIDS society
accessLevelPublic
2019 383 141
Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing?Clinical Infectious Diseases
accessLevelPublic
2019 532 155
Programme national de lutte contre le VIH, les IST et l'hépatite virale: unir les forces contre le VIH et les hépatites viralesBulletin des médecins suisses
accessLevelPublic
2019 463 187
Research priorities to inform "Treat All" policy implementation for people living with HIV in sub-Saharan Africa: a consensus statement from the International epidemiology Databases to Evaluate AIDS (IeDEA)Journal of the International AIDS society
accessLevelPublic
2019 770 437
Timing of combination antiretroviral therapy (cART) initiation is not associated with stillbirth among HIV-infected pregnant women in MalawiTropical Medicine & International Health
accessLevelPublic
2019 474 203
Socio‐behavioural characteristics and HIV: findings from a graphical modelling analysis of 29 sub‐Saharan African countriesJournal of the International AIDS society
accessLevelPublic
2019 382 154
Why do sub‐Saharan Africans present late for HIV care in Switzerland ?HIV medicine
accessLevelRestricted
2019 77 0
On the potential of a short-term intensive intervention to interrupt HCV transmission in HIV-positive men who have sex with men: A mathematical modelling studyJournal of viral hepatitis
accessLevelPublic
2018 1,737 460
How should HIV resources be allocated? Lessons learnt from applying Optima HIV in 23 countriesJournal of the International AIDS society
accessLevelPublic
2018 630 245
Eliminating hepatitis C virus as a public health threat among HIV-positive men who have sex with men: a multi-modelling approach to understand differences in sexual risk behaviourJournal of the International AIDS society
accessLevelPublic
2018 1,625 358
Long-term Immune Response to Yellow Fever Vaccination in Human Immunodeficiency Virus (HIV)-Infected Individuals Depends on HIV RNA Suppression Status: Implications for Vaccination ScheduleClinical infectious diseases
accessLevelRestricted
2018 81 0
Patterns of caesarean section in HIV infected and non-infected women in Malawi: is caesarean section used for PMTCT?BMC Pregnancy and Childbirth
accessLevelPublic
2018 550 193
Impact of Screening and Treatment for Hepatitis C Virus (HCV) Infection in Switzerland. A Comprehensive Mathematical Model of the Swiss HCV Epidemic
accessLevelPublic
2018 573 143
The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDSThe Lancet HIV
accessLevelPublic
2018 1,173 474
Mathematical modelling to inform 'treat all' implementation in sub-Saharan Africa: a scoping reviewJournal of Virus Eradication
accessLevelPublic
2018 391 125
The Effect of Monitoring Viral Load and Tracing Patients Lost to Follow-up on the Course of the HIV Epidemic in Malawi: A Mathematical ModelOpen Forum Infectious Diseases
accessLevelPublic
2018 1,495 347
Combler les lacunes dans les tests de dépistage de l'hépatiteBulletin des médecins suisses
accessLevelPublic
2018 463 174
HIV-1 Drug Resistance and Third-Line Therapy Outcomes in Patients Failing Second-Line Therapy in ZimbabweOpen Forum Infectious Diseases
accessLevelPublic
2018 681 238
Weight gain of HIV-exposed, uninfected children born before and after introduction of the "Option B+" programme in MalawiAIDS
accessLevelPublic
2018 439 186
Cohort profile: The MULTI sTUdy Diabetes rEsearch (MULTITUDE) consortiumBMJ Open
accessLevelPublic
2018 542 191
Outcomes of Patients Lost to Follow-up in African Antiretroviral Therapy Programs: Individual Patient Data Meta-analysisClinical Infectious Diseases
accessLevelPublic
2018 463 166
Subclinical coronary artery disease in Swiss HIV-positive and HIV-negative personsEuropean heart journal
accessLevelRestricted
2018 95 0
A community outbreak of Legionnaires' disease in Geneva, Switzerland, June to September 2017Swiss Medical Weekly
accessLevelPublic
2018 516 227
"I found that I was well and strong": Women's motivations for remaining on ART under Option B+ in MalawiPLOS ONE
accessLevelPublic
2018 553 196
HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programmeJournal of the International AIDS society
accessLevelPublic
2017 603 316
The cascade of care to prevent mother-to-child transmission in Rio de Janeiro, Brazil, 1996-2013: improving but still some way to goTropical Medicine & International Health
accessLevelPublic
2017 504 322
New-onset type 2 diabetes mellitus among patients receiving HIV care at Newlands Clinic, Harare, Zimbabwe: retrospective cohort analysisTropical Medicine & International Health
accessLevelPublic
2017 569 239
Getting it right when budgets are tight: Using optimal expansion pathways to prioritize responses to concentrated and mixed HIV epidemicsPLOS ONE
accessLevelPublic
2017 562 257
Trends in hepatitis C-related mortality in SwitzerlandJournal of Hepatology
accessLevelPublic
2017 1,244 684
Impact of screening and antiretroviral therapy on anal cancer incidence in HIV-positive MSMAIDS
accessLevelPublic
2017 585 350
The J-Curve in HIV: Low and Moderate Alcohol Intake Predicts Mortality but Not the Occurrence of Major Cardiovascular EventsJournal of acquired immune deficiency syndromes
accessLevelRestricted
2016 81 0
Ability to Work and Employment Rates in Human Immunodeficiency Virus (HIV)-1-Infected Individuals Receiving Combination Antiretroviral Therapy : The Swiss HIV Cohort StudyOpen forum infectious diseases
accessLevelPublic
2016 80 26
Hepatitis C virus transmission among human immunodeficiency virus-infected men who have sex with men: Modeling the effect of behavioral and treatment interventionsHepatology
accessLevelPublic
2016 689 253
Characteristics of Foreign-Born Persons in the Swiss Hepatitis C Cohort Study: Implications for Screening RecommendationsPloS one
accessLevelPublic
2016 624 535
Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort studyInternational journal of cancer
accessLevelPublic
2016 681 264
Emergence of Acquired HIV-1 Drug Resistance Almost Stopped in Switzerland: A 15-Year Prospective Cohort AnalysisClinical Infectious Diseases
accessLevelRestricted
2016 671 1
HIV-1 Transmission During Recent Infection and During Treatment Interruptions as Major Drivers of New Infections in the Swiss HIV Cohort StudyClinical Infectious Diseases
accessLevelPublic
2016 502 164
Increases in Condomless Sex in the Swiss HIV Cohort StudyOpen forum infectious diseases
accessLevelPublic
2015 84 28
Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort StudyBMC infectious diseases
accessLevelPublic
2015 99 53
Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in SwitzerlandAIDS
accessLevelRestricted
2015 85 0
Reasons for late presentation to HIV care in SwitzerlandJournal of the International AIDS Society
accessLevelPublic
2015 66 19
Effect of Cumulating Exposure to Abacavir on the Risk of Cardiovascular Disease Events in Patients From the Swiss HIV Cohort StudyJournal of acquired immune deficiency syndromes
accessLevelPublic
2015 95 22
HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected personsBMC gastroenterology
accessLevelPublic
2015 71 19
Self-reported nonadherence to antiretroviral therapy as a predictor of viral failure and mortalityAIDS
accessLevelRestricted
2015 70 0
Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in ZambiaClinical infectious diseases
accessLevelPublic
2014 718 273
Social Meets Molecular: Combining Phylogenetic and Latent Class Analyses to Understand HIV-1 Transmission in SwitzerlandAmerican journal of epidemiology
accessLevelPublic
2014 857 51
Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backboneHIV clinical trials
accessLevelRestricted
2014 75 0
Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort StudyAmerican journal of epidemiology
accessLevelRestricted
2013 662 0
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infectionBritish journal of cancer
accessLevelPublic
2012 575 1,069
Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort StudyJournal of acquired immune deficiency syndromes
accessLevelRestricted
2012 625 0
Estimating loss to follow-up in HIV-infected patients on antiretroviral therapy: the effect of the competing risk of death in Zambia and SwitzerlandPloS one
accessLevelPublic
2011 1,270 359
Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients : The ACHIEV2E Collaboration Study GroupClinical infectious diseases
accessLevelRestricted
2011 98 0
A randomized crossover study to compare efavirenz and etravirine treatmentAIDS
accessLevelRestricted
2011 99 0
Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapyGut
accessLevelRestricted
2010 647 0
Pregnancy and delivery outcomes of HIV infected women in Switzerland 2003-2008Journal of perinatal medicine
accessLevelRestricted
2010 685 0
Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008The American journal of psychiatry
2010 678 0
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort StudyBritish journal of cancer
accessLevelRestricted
2010 790 1
Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort StudyHIV medicine
accessLevelRestricted
2009 618 0
Public-health and individual approaches to antiretroviral therapy: township South Africa and Switzerland comparedPLoS medicine
accessLevelPublic
2008 846 365
Antiretroviral treatment during pregnancyAIDS
accessLevelRestricted
2008 664 0
Durability and outcome of initial antiretroviral treatments received during 2000--2005 by patients in the Swiss HIV Cohort StudyThe Journal of infectious diseases
accessLevelRestricted
2008 637 0
Active intravenous drug use during chronic hepatitis C therapy does not reduce sustained virological response rates in adherent patientsJournal of viral hepatitis
accessLevelRestricted
2008 640 0
Adverse events to antiretrovirals in the Swiss HIV Cohort Study: effect on mortality and treatment modificationAntiviral therapy
accessLevelRestricted
2007 571 1
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack